Associate Director
Revolution Medicines
Associate Director
Revolution Medicines
Clinical-stage oncology company developing RAS inhibitors
Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.
Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.
The Opportunity:
Revolution Medicines is seeking an Associate Director, US Pricing Contract Operations, to lead and manage operational effectiveness, compliance, and business outcomes for provider and government payer contracting operations. Responsibilities include leading contract operations include oversight of: Medicare, Medicaid, TRICARE rebate processing as well as commercial customer contract processing, analytics and business insights. Analytics will involve regular segment account mapping, in-depth purchasing analytics and modeling GPO contract performance outputs that translate to strategic pricing recommendations. Additionally, collaborations with external GPO operations team, Oncology National Accounts team and strategic pricing team to develop and recommend baseline measurements, KPI analytics and contract strategy insights that aligns with site-of-care, reimbursement, and policy considerations. This includes directing all operations of commercial and government rebates processing and communicating key market insights to US Market Access and Pricing leadership.
The Associate Director will report to the Senior Director, US Strategic Pricing and will serve in a critical function to lead, analyze, and execute end-to-end contract process operations and insights as the company grows as a commercial organization. This role will work closely with US and Commercial leadership, Distribution, Finance, as well as broader Commercial organization.
This role can be based in Redwood City, CA location or can be remotely based with up to 15% travel.
Key Responsibilities
Plan, drive, and deliver processes for Medicare, Medicaid and TRICARE quarterly rebate payment processing.
Create and communicate senior level quarterly insights to inform gross-to-net actuals to USMA and finance.
Track and analyze customer segment and purchasing trends that inform pricing strategies and outline optimal business outcomes.
Build and maintain streamlined GPO member account mapping, distributors and affiliations to create a consistent view of purchasing and contract performance over time.
Review and maintain member rosters and manage eligibility based on defined criteria.
Perform contract performance reporting and analytics, including recurring reports and Quarterly Business Reviews for GPO partners and internal stakeholders.
Build efficient department capabilities that calculate and maintain GPO baselines and validate rebate, admin fee and accrual calculations.
Respond to and resolve internal and external questions related to GPO contracts, pricing, baselines and rebates.
Partner with National Accounts and Contracting leads and communicate quarterly contract performance and emerging customer purchasing and pricing strategies.
Deliver strategic contracting recommendations with contract analytics, using multi-year purchasing history to inform leadership.
Drive cross-functional collaboration with US Market Access, Finance, and National Accounts to align GPO contract performance communications.
Maintain compliant policy and standard operating procedures for contract validation, eligible membership and process flow.
Ensure contract processes are working efficiently, identify root cause of issues, and recommend corrective action to eliminate future occurrences.
Provide ad hoc analytics as requested, utilizing available reporting tools and building new tools as needed.
Support other analytic projects and strategic initiatives within the team.
Identify and articulate improvement initiatives aligned with group and departmental goals and actively lead and/or participate in process improvement projects.
Attend industry conferences on an as-needed basis.
Perform other related job responsibilities as assigned.
Required Skills, Experience and Education:
Bachelor’s degree.
8+ years of pharmaceutical pricing operation experience.
5+ years of Oncology product experience.
5+ years pricing, and payer/provider contracting experience to support government and discretionary discounts.
Extensive experience and demonstrated success in government and provider customer segment contract operations, oncology market knowledge, and pricing policies to support products and/or portfolio strategies.
Deep analytic skills that provide key business insights.
Experience with day-to-day management of vendor partners.
Ability to communicate effectively, both orally and in writing.
Embrace cross-functional collaboration with internal and external customers; possesses interpersonal skills to develop and maintain cooperative working and business relationships.
Ability to effectively resolve conflicts and multi-department alignment to delivery commercial goals and objectives.
#LI-SS2 #LI-Remote
The base pay salary range for this full-time position for candidates working onsite at our headquarters in Redwood City, CA is listed below. The range displayed on each job posting is intended to be the base pay salary range for an individual working onsite in Redwood City and will be adjusted for the local market a candidate is based in. Our base pay salary ranges are determined by role, level, and location. Individual base pay salary is determined by multiple factors, including job-related skills, experience, market dynamics, and relevant education or training.
Please note that base pay salary range is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities.
Revolution Medicines is an equal opportunity employer and prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital status, medical condition, and veteran status.
Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact [email protected].
We are aware of recent recruitment scams in which individuals or organizations falsely represent themselves as being affiliated with Revolution Medicines. These scams may appear as false job advertisements or unsolicited contacts through communication or chat platforms, email, phone, or text message.
Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information, purchase equipment, or pay fees as part of the hiring process. All legitimate communication from Revolution Medicines will come from an official @revmed.com email address.
If you believe you’ve been contacted by someone impersonating a Revolution Medicines recruiter, please report it to [email protected] so we can share these impersonations with our IT team for tracking and awareness.
Base Pay Salary Range 177000 - 221000 USD
Clinical-stage oncology company developing RAS inhibitors
Revolution Medicines develops precision oncology drugs focused on cancers driven by RAS mutations. Its RAS(ON) inhibitors are small molecules that bind the active form of RAS to block cancer signaling, with candidates like Daraxonrasib (RMC-6236), Elironrasib (RMC-6291), and Zoldonrasib (RMC-9805) advancing in global Phase 3 trials. The company funds its research through collaborations, royalties, and upfront funding, and has not yet marketed a product. Its goal is to bring effective RAS-targeted therapies to patients and advance multiple candidates through late-stage trials toward approval, supported by strong cash reserves.
Explore more opportunities at Revolution Medicines